目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED
1.2.4 CURRENCY CONSIDERED
1.3 STAKEHOLDERS
1.4 LIMITATIONS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN INTERVENTIONAL ONCOLOGY MARKET
4.2 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES AND COUNTRY, 2023
4.3 INTERVENTIONAL ONCOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 INTERVENTIONAL ONCOLOGY MARKET, BY REGION, 2024-2029
4.5 INTERVENTIONAL ONCOLOGY MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising preference for minimally invasive procedures
5.2.1.2 Growing prevalence of cancer
5.2.1.3 Increasing public-private funding and government support for interventional oncology
5.2.1.4 Technological advancements in interventional oncology
5.2.2 RESTRAINTS
5.2.2.1 High cost of interventional oncology
5.2.2.2 Unfavorable regulations
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high-growth potential
5.2.4 CHALLENGES
5.2.4.1 Dearth of well-trained and skilled radiologists and oncologists
5.2.4.2 Strong market position of alternative therapies
5.3 INDUSTRY TRENDS
5.3.1 INNOVATIONS IN IMAGING AND TREATMENT TECHNOLOGIES
5.3.2 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
5.4 VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGIES
5.5.1.1 Ablation technologies
5.5.1.2 Embolization technologies
5.5.2 COMPLEMENTARY TECHNOLOGY
5.5.2.1 Laparoscopy
5.5.2.2 Diagnostic imaging
5.5.3 ADJACENT TECHNOLOGY
5.5.3.1 Radiation therapy systems
5.5.3.2 Chemotherapy
5.6 PORTER'S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 KEY STAKEHOLDERS AND BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.7.2 BUYING CRITERIA
5.8 REGULATORY LANDSCAPE
5.8.1 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
5.8.2 KEY REGULATORY GUIDELINES
5.8.2.1 US
5.8.2.2 Canada
5.8.2.3 Europe
5.8.2.4 Asia Pacific
5.8.2.4.1 Japan
5.8.2.4.2 China
5.8.2.4.3 India
5.8.2.5 Brazil
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR INTERVENTIONAL ONCOLOGY, JANUARY 2014-DECEMBER 2024
5.11 TRADE ANALYSIS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE OF INTERVENTIONAL ONCOLOGY DEVICES, BY KEY PLAYER, 2023
5.12.2 AVERAGE SELLING PRICE OF INTERVENTIONAL ONCOLOGY DEVICES, BY KEY PLAYER, 2023 (USD)
5.12.3 AVERAGE SELLING PRICE TREND OF INTERVENTIONAL ONCOLOGY DEVICES, BY REGION, 2021-2023
5.13 KEY CONFERENCES AND EVENTS, 2025-2026
5.14 UNMET NEEDS AND END USER EXPECTATIONS
5.14.1 UNMET NEEDS
5.15 END USER EXPECTATIONS IN INTERVENTIONAL ONCOLOGY MARKET
5.16 ECOSYSTEM
5.17 CASE STUDIES
5.18 SUPPLY CHAIN ANALYSIS
5.19 ADJACENT MARKET ANALYSIS
5.20 INTERVENTIONAL ONCOLOGY MARKET, INVESTMENT AND FUNDING SCENARIO, 2020-2023
5.21 IMPACT OF GENERATIVE AI ON INTERVENTIONAL ONCOLOGY MARKET

6 INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES
6.1 INTRODUCTION
6.2 EMBOLIZATION DEVICES
6.2.1 RADIOEMBOLIC AGENTS
6.2.1.1 Precision-targeted therapy for challenging liver cancers to boost market
6.2.2 NON-RADIOACTIVE EMBOLIC AGENTS
6.2.2.1 Non-radiation emitting agents to propel market
6.2.2.2 Microspheres
6.2.2.2.1 Surge in prevalence of hepatocellular carcinoma to fuel growth
6.2.2.3 Coated beads
6.2.2.3.1 Specialized polymer coatings with enhanced ability to bind, absorb, and release chemotherapeutic agents to drive market
6.2.2.4 Microparticles
6.2.2.4.1 Use in various cancer applications to drive growth
6.3 ABLATION DEVICES
6.3.1 RADIOFREQUENCY (RF) ABLATION DEVICES
6.3.1.1 Effective treatment of small or difficult-to-reach tumors to propel market growth
6.3.2 MICROWAVE ABLATION DEVICES
6.3.2.1 Simultaneous treatment of multiple lesions to drive market growth
6.3.3 CRYOABLATION DEVICES
6.3.3.1 Least painful and higher patient compatibility to drive market
6.3.4 OTHER ABLATION DEVICES
6.4 SUPPORT DEVICES
6.4.1 MICROCATHETERS
6.4.1.1 Precise delivery of therapeutic agents to tumors to boost market
6.4.2 GUIDEWIRES
6.4.2.1 Advancements in guidewire construction and launch of new and advanced products to propel market
6.4.3 OTHER SUPPORT DEVICES

7 INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE
7.1 INTRODUCTION
7.2 LIVER CANCER
7.2.1 INCREASING DISEASE PREVALENCE AND RISING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
7.3 KIDNEY CANCER
7.3.1 FIRST-LINE THERAPY PRESERVING MORE KIDNEY TISSUE THAN SURGERY TO BOOST MARKET
7.4 BREAST CANCER
7.4.1 HIGH PRECISION, BETTER COSMETIC OUTCOMES, COST-EFFECTIVENESS, AND GREATER PATIENT COMFORT TO PROPEL MARKET
7.5 LUNG CANCER
7.5.1 INCREASING NUMBER OF CANCER CASES TO DRIVE DEMAND
7.6 BONE CANCER
7.6.1 DIRECT ELIMINATION OF TUMORS AND PAIN RELIEF TO FUEL MARKET
7.7 PROSTATE CANCER
7.7.1 RISING INCIDENCE OF PROSTATE CANCER AND GROWING ADOPTION OF METAL-BASED FIDUCIAL MARKERS TO CONTRIBUTE TO MARKET GROWTH
7.8 OTHER CANCER TYPES

8 INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE
8.1 INTRODUCTION
8.2 TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY (TARE/SIRT)
8.2.1 GREATER CLINICAL EFFICACY TO DRIVE MARKET GROWTH
8.3 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)
8.3.1 ABILITY TO TREAT SMALL AND LARGE-SIZED TUMORS TO DRIVE DEMAND
8.4 TRANSCATHETER ARTERIAL EMBOLIZATION/BLAND EMBOLIZATION (TAE)
8.4.1 INCREASING CLINICAL EVIDENCE IN FAVOR OF TARE AND TACE TO RESTRAIN MARKET GROWTH
8.5 THERMAL TUMOR ABLATION
8.5.1 GROWING CLINICAL EVIDENCE PROVING EFFICACY OF TREATMENT OF VARIOUS TYPES OF CANCERS TO DRIVE MARKET GROWTH
8.6 NON-THERMAL TUMOR ABLATION
8.6.1 POTENTIAL ALTERNATIVE TO THERMAL TUMOR ABLATION TO BOOST MARKET

9 INTERVENTIONAL ONCOLOGY MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 INCREASING NUMBER OF SURGERIES IN IN-PATIENT SETTINGS TO SUPPORT MARKET GROWTH
9.3 SPECIALTY CLINICS
9.3.1 INCREASING NUMBER OF CANCER CENTERS TO DRIVE MARKET GROWTH
9.4 RESEARCH & ACADEMIC INSTITUTES
9.4.1 COLLABORATIONS AMONG DEVICE MANUFACTURERS AND SUPPLIERS TO FUEL MARKET

10 INTERVENTIONAL ONCOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Rising cancer cases and preference for ablation procedures to boost market
10.2.3 CANADA
10.2.3.1 Significant rise in cancer cases to drive market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increase in incidence of cancer and rising geriatric population to fuel market
10.3.3 UK
10.3.3.1 Increasing awareness and support for cancer-related activities to drive market
10.3.4 FRANCE
10.3.4.1 Growing geriatric population to support market growth
10.3.5 SPAIN
10.3.5.1 Increasing government funding for research to support market growth
10.3.6 ITALY
10.3.6.1 Growing awareness about cancer and treatment options to support market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and universal healthcare reimbursement to drive market
10.4.3 CHINA
10.4.3.1 Increasing incidence of cancer to drive market
10.4.4 INDIA
10.4.4.1 Improving research capabilities and expansion of key players to drive market growth
10.4.5 AUSTRALIA
10.4.5.1 Rising investments in research and awareness campaigns to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Rising incidence of cancer and improving healthcare infrastructure to fuel market
10.5.3 MEXICO
10.5.3.1 Increasing awareness campaigns and rising incidence of cancer to drive market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.2.1 Broader healthcare modernization initiatives in interventional oncology to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
11.3 REVENUE ANALYSIS, 2019-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Devices & Consumables footprint
11.5.5.4 Cancer type footprint
11.5.5.5 Procedure footprint
11.5.5.6 End user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
11.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SMES, 2023
11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC)
12.1.1.1 Business overview
12.1.1.2 Products/Solutions/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 BOSTON SCIENTIFIC CORPORATION
12.1.2.1 Business overview
12.1.2.2 Products/Solutions/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches & approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 MEDTRONIC
12.1.3.1 Business overview
12.1.3.2 Products/Solutions/Services offered
12.1.3.3 MnM view
12.1.3.3.1 Right to win
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses and competitive threats
12.1.4 TERUMO CORPORATION
12.1.4.1 Business overview
12.1.4.2 Products/Solutions/Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 MERIT MEDICAL SYSTEMS
12.1.5.1 Business overview
12.1.5.2 Products/Solutions/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 JOHNSON & JOHNSON MEDTECH (ETHICON)
12.1.6.1 Business overview
12.1.6.2 Products/Solutions/Services offered
12.1.7 TELEFLEX INCORPORATED
12.1.7.1 Business overview
12.1.7.2 Products/Solutions/Services offered
12.1.8 ANGIODYNAMICS
12.1.8.1 Business overview
12.1.8.2 Products/Solutions/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches & approvals
12.1.9 STRYKER
12.1.9.1 Business overview
12.1.9.2 Products/Solutions/Services offered
12.1.10 IMBIOTECHNOLOGIES LTD.
12.1.10.1 Business overview
12.1.10.2 Products/Solutions/Services offered
12.1.11 COOK
12.1.11.1 Business overview
12.1.11.2 Products/Solutions/Services offered
12.1.12 ICECURE MEDICAL
12.1.12.1 Business overview
12.1.12.2 Products/Solutions/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product approvals
12.1.12.3.2 Deals
12.1.13 MEDWAVES, INC.
12.1.13.1 Business overview
12.1.13.2 Products/Solutions/Services offered
12.1.14 PROFOUND MEDICAL
12.1.14.1 Business overview
12.1.14.2 Products/Solutions/Services offered
12.1.15 RF MEDICAL CO., LTD.
12.1.15.1 Business overview
12.1.15.2 Products/Solutions/Services offered
12.1.16 MINIMAX MEDICAL LIMITED
12.1.16.1 Business overview
12.1.16.2 Products/Solutions/Services offered
12.1.17 ABK BIOMEDICAL INC.
12.1.17.1 Business overview
12.1.17.2 Products/Solutions/Services offered
12.1.18 OLYMPUS CORPORATION
12.1.18.1 Business overview
12.1.18.2 Products/Solutions/Services offered
12.1.19 SURGNOVA
12.1.19.1 Business overview
12.1.19.2 Products/Solutions/Services offered
12.1.20 STARMED AMERICA
12.1.20.1 Business overview
12.1.20.2 Products/Solutions/Services offered
12.2 OTHER PLAYERS
12.2.1 SIRTEX SIR-SPHERES PTY LTD.
12.2.2 GUERBET
12.2.3 ACCURAY INCORPORATED
12.2.4 EMBOLX, INC.
12.2.5 SONABLATE CORP.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

List of Tables
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 RISK ASSESSMENT: INTERVENTIONAL ONCOLOGY MARKET
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMBOLIZATION DEVICES, ABLATION DEVICES, AND SUPPORT DEVICES
TABLE 4 KEY BUYING CRITERIA FOR EMBOLIZATION DEVICES, ABLATION DEVICES, AND SUPPORT DEVICES
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
TABLE 6 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
TABLE 9 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 13 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 16 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES
TABLE 17 LIST OF PATENTS IN INTERVENTIONAL ONCOLOGY MARKET, 2021-2024
TABLE 18 IMPORT DATA FOR INTERVENTIONAL ONCOLOGY (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 19 EXPORT DATA FOR INTERVENTIONAL ONCOLOGY (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 20 AVERAGE SELLING PRICE OF INTERVENTIONAL ONCOLOGY DEVICES, BY KEY PLAYER, 2023 (USD)
TABLE 21 AVERAGE SELLING PRICE TREND OF INTERVENTIONAL ONCOLOGY DEVICES, BY REGION, 2021-2023
TABLE 22 INTERVENTIONAL ONCOLOGY MARKET: KEY CONFERENCES & EVENTS, 2025-2026
TABLE 23 END USER EXPECTATIONS FOR EMBOLIZATION DEVICES, ABLATION DEVICES, AND SUPPORT DEVICES
TABLE 24 INTERVENTIONAL ONCOLOGY MARKET: ECOSYSTEM ANALYSIS
TABLE 25 TREATMENT OF HEPATOCELLULAR CARCINOMA WITH ARTERIOPORTAL SHUNTING USING BALLOON-ASSISTED TRANSARTERIAL YTTRIUM-90 RADIATION SEGMENTECTOMY
TABLE 26 RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
TABLE 27 UPPER POLE ANGIOMYOLIPOMA (AML) EMBOLIZATION
TABLE 28 INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 29 INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 30 INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 31 INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 32 INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 33 INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 34 RADIOEMBOLIC AGENTS OFFERED BY MAJOR MARKET PLAYERS
TABLE 35 INTERVENTIONAL ONCOLOGY MARKET FOR RADIOEMBOLIC AGENTS, BY REGION, 2019-2023 (USD MILLION)
TABLE 36 INTERVENTIONAL ONCOLOGY MARKET FOR RADIOEMBOLIC AGENTS, BY REGION, 2024-2029 (USD MILLION)
TABLE 37 NON-RADIOACTIVE EMBOLIC AGENTS OFFERED BY MAJOR MARKET PLAYERS
TABLE 38 INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE EMBOLIC AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 39 INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE EMBOLIC AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 40 INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE EMBOLIC AGENTS, BY REGION, 2019-2023 (USD MILLION)
TABLE 41 INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE EMBOLIC AGENTS, BY REGION, 2024-2029 (USD MILLION)
TABLE 42 INTERVENTIONAL ONCOLOGY MARKET FOR MICROSPHERES, BY REGION, 2019-2023 (USD MILLION)
TABLE 43 INTERVENTIONAL ONCOLOGY MARKET FOR MICROSPHERES, BY REGION, 2024-2029 (USD MILLION)
TABLE 44 INTERVENTIONAL ONCOLOGY MARKET FOR COATED BEADS, BY REGION, 2019-2023 (USD MILLION)
TABLE 45 INTERVENTIONAL ONCOLOGY MARKET FOR COATED BEADS, BY REGION, 2024-2029 (USD MILLION)
TABLE 46 MAJOR BRANDS OF MICROCARRIERS
TABLE 47 INTERVENTIONAL ONCOLOGY MARKET FOR MICROPARTICLES, BY REGION, 2019-2023 (USD MILLION)
TABLE 48 INTERVENTIONAL ONCOLOGY MARKET FOR MICROPARTICLES, BY REGION, 2024-2029 (USD MILLION)
TABLE 49 INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 50 INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 51 INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 52 INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 53 RADIOFREQUENCY ABLATION DEVICES OFFERED BY MAJOR MARKET PLAYERS
TABLE 54 INTERVENTIONAL ONCOLOGY MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 55 INTERVENTIONAL ONCOLOGY MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 56 RADIOFREQUENCY ABLATION SYSTEMS, BY REGION, 2023-2029 (THOUSAND UNITS)
TABLE 57 INTERVENTIONAL ONCOLOGY MARKET FOR MICROWAVE ABLATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 58 INTERVENTIONAL ONCOLOGY MARKET FOR MICROWAVE ABLATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 59 MICROWAVE ABLATION SYSTEMS, BY REGION, 2023-2029 (THOUSAND UNITS)
TABLE 60 INTERVENTIONAL ONCOLOGY MARKET FOR CRYOABLATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 61 INTERVENTIONAL ONCOLOGY MARKET FOR CRYOABLATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 62 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER ABLATION DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 63 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER ABLATION DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 64 INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 65 INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 66 INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 67 INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 68 INTERVENTIONAL ONCOLOGY MARKET FOR MICROCATHETERS, BY REGION, 2019-2023 (USD MILLION)
TABLE 69 INTERVENTIONAL ONCOLOGY MARKET FOR MICROCATHETERS, BY REGION, 2024-2029 (USD MILLION)
TABLE 70 INTERVENTIONAL ONCOLOGY MARKET FOR GUIDEWIRES, BY REGION, 2019-2023 (USD MILLION)
TABLE 71 INTERVENTIONAL ONCOLOGY MARKET FOR GUIDEWIRES, BY REGION, 2024-2029 (USD MILLION)
TABLE 72 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER SUPPORT DEVICES, BY REGION, 2019-2023 (USD MILLION)
TABLE 73 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER SUPPORT DEVICES, BY REGION, 2024-2029 (USD MILLION)
TABLE 74 INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 75 INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 76 INTERVENTIONAL ONCOLOGY MARKET FOR LIVER CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 77 INTERVENTIONAL ONCOLOGY MARKET FOR LIVER CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 78 INTERVENTIONAL ONCOLOGY MARKET FOR KIDNEY CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 79 INTERVENTIONAL ONCOLOGY MARKET FOR KIDNEY CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 80 INTERVENTIONAL ONCOLOGY MARKET FOR BREAST CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 81 INTERVENTIONAL ONCOLOGY MARKET FOR BREAST CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 82 INTERVENTIONAL ONCOLOGY MARKET FOR LUNG CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 83 INTERVENTIONAL ONCOLOGY MARKET FOR LUNG CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 84 INTERVENTIONAL ONCOLOGY MARKET FOR BONE CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 85 INTERVENTIONAL ONCOLOGY MARKET FOR BONE CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 86 INTERVENTIONAL ONCOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2019-2023 (USD MILLION)
TABLE 87 INTERVENTIONAL ONCOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2024-2029 (USD MILLION)
TABLE 88 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER CANCER TYPES, BY REGION, 2019-2023 (USD MILLION)
TABLE 89 INTERVENTIONAL ONCOLOGY MARKET FOR OTHER CANCER TYPES, BY REGION, 2024-2029 (USD MILLION)
TABLE 90 INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 91 INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 92 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY (TARE/SIRT), BY REGION, 2019-2023 (USD MILLION)
TABLE 93 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY (TARE/SIRT), BY REGION, 2024-2029 (USD MILLION)
TABLE 94 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE), BY REGION, 2019-2023 (USD MILLION)
TABLE 95 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE), BY REGION, 2024-2029 (USD MILLION)
TABLE 96 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL EMBOLIZATION/BLAND EMBOLIZATION (TAE), BY REGION, 2019-2023 (USD MILLION)
TABLE 97 INTERVENTIONAL ONCOLOGY MARKET FOR TRANSCATHETER ARTERIAL EMBOLIZATION/BLAND EMBOLIZATION (TAE), BY REGION, 2024-2029 (USD MILLION)
TABLE 98 INTERVENTIONAL ONCOLOGY MARKET FOR THERMAL TUMOR ABLATION, BY REGION, 2019-2023 (USD MILLION)
TABLE 99 INTERVENTIONAL ONCOLOGY MARKET FOR THERMAL TUMOR ABLATION, BY REGION, 2024-2029 (USD MILLION)
TABLE 100 INTERVENTIONAL ONCOLOGY MARKET FOR NON-THERMAL TUMOR ABLATION, BY REGION, 2019-2023 (USD MILLION)
TABLE 101 INTERVENTIONAL ONCOLOGY MARKET FOR NON-THERMAL TUMOR ABLATION, BY REGION, 2024-2029 (USD MILLION)
TABLE 102 INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 103 INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 104 INTERVENTIONAL ONCOLOGY MARKET FOR HOSPITALS, BY REGION, 2019-2023 (USD MILLION)
TABLE 105 INTERVENTIONAL ONCOLOGY MARKET FOR HOSPITALS, BY REGION, 2024-2029 (USD MILLION)
TABLE 106 INTERVENTIONAL ONCOLOGY MARKET FOR SPECIALTY CLINICS, BY REGION, 2019-2023 (USD MILLION)
TABLE 107 INTERVENTIONAL ONCOLOGY MARKET FOR SPECIALTY CLINICS, BY REGION, 2024-2029 (USD MILLION)
TABLE 108 INTERVENTIONAL ONCOLOGY MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019-2023 (USD MILLION)
TABLE 109 INTERVENTIONAL ONCOLOGY MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2029 (USD MILLION)
TABLE 110 INTERVENTIONAL ONCOLOGY MARKET, BY REGION, 2019-2023 (USD MILLION)
TABLE 111 INTERVENTIONAL ONCOLOGY MARKET, BY REGION, 2024-2029 (USD MILLION)
TABLE 112 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 113 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 114 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 115 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 116 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 117 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 118 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 119 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 120 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 121 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 122 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 123 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 124 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 125 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 126 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 127 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 128 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 129 NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 130 US: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 131 US: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 132 US: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 133 US: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 134 US: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 135 US: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 136 US: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 137 US: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 138 US: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 139 US: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 140 US: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 141 US: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 142 US: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 143 US: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 144 US: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 145 US: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 146 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 147 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 148 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 149 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 150 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 151 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 152 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 153 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 154 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 155 CANADA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 156 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 157 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 158 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 159 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 160 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 161 CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 162 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 163 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 164 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 165 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 166 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 167 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 168 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 169 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 170 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 171 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 172 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 173 EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 174 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 175 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 176 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 177 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 178 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 179 EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 180 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 181 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 182 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 183 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 184 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 185 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 186 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 187 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 188 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 189 GERMANY: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 190 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 191 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 192 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 193 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 194 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 195 GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 196 UK: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 197 UK: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 198 UK: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 199 UK: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 200 UK: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 201 UK: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 202 UK: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 203 UK: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 204 UK: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 205 UK: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 206 UK: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 207 UK: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 208 UK: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 209 UK: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 210 UK: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 211 UK: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 212 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 213 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 214 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 215 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 216 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 217 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 218 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 219 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 220 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 221 FRANCE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 222 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 223 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 224 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 225 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 226 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 227 FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 228 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 229 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 230 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 231 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 232 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 233 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 234 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 235 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 236 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 237 SPAIN: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 238 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 239 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 240 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 241 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 242 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 243 SPAIN: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 244 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 245 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 246 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 247 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 248 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 249 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 250 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 251 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 252 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 253 ITALY: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 254 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 255 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 256 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 257 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 258 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 259 ITALY: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 260 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 261 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 262 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 263 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 264 REST OF EUROPE INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 265 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 266 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 267 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 268 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 269 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 270 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 271 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 272 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 273 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 274 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 275 REST OF EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 276 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 277 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 278 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 279 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 280 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 281 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 283 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 284 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 285 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 286 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 287 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 288 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 289 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 290 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 291 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 292 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 293 ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 294 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 295 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 296 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 297 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 298 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 299 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 300 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 301 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 302 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 303 JAPAN: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 304 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 305 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 306 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 307 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 308 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 309 JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 310 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 311 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 312 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 313 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 314 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 315 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 316 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 317 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 318 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 319 CHINA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 320 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 321 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 322 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 323 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 324 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 325 CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 326 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 327 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 328 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 329 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 330 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 331 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 332 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 333 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 334 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 335 INDIA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 336 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 337 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 338 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 339 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 340 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 341 INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 342 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 343 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 344 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 345 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 346 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 347 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 348 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 349 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 350 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 351 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 352 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 353 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 354 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 355 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 356 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 357 AUSTRALIA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 358 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 359 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 360 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 361 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 362 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 363 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 364 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 365 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 366 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 367 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 368 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 369 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 370 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 371 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 372 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 373 SOUTH KOREA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 374 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 375 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 376 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 377 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 378 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 379 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 380 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 381 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 382 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 383 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 384 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 385 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 386 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 387 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 388 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 389 REST OF ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 390 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 391 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 392 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 393 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 394 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 395 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 396 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 397 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 398 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 399 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 400 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 401 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 402 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 403 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 404 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 405 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 406 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 407 LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 408 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 409 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 410 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 411 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 412 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 413 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 414 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 415 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 416 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 417 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 418 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 419 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 420 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 421 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 422 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 423 BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 424 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 425 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 426 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 427 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 428 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 429 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 430 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 431 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 432 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 433 MEXICO: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 434 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 435 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 436 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 437 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 438 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 439 MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 440 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2019-2023 (USD MILLION)
TABLE 441 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY DEVICES & CONSUMABLES, 2024-2029 (USD MILLION)
TABLE 442 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 443 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 444 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2019-2023 (USD MILLION)
TABLE 445 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR NON-RADIOACTIVE AGENTS, BY TYPE, 2024-2029 (USD MILLION)
TABLE 446 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 447 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR ABLATION DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 448 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2019-2023 (USD MILLION)
TABLE 449 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET FOR SUPPORT DEVICES, BY TYPE, 2024-2029 (USD MILLION)
TABLE 450 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2019-2023 (USD MILLION)
TABLE 451 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2024-2029 (USD MILLION)
TABLE 452 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019-2023 (USD MILLION)
TABLE 453 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2024-2029 (USD MILLION)
TABLE 454 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2019-2023 (USD MILLION)
TABLE 455 REST OF LATIN AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY END USER, 2024-2029 (USD MILLION)
TABLE 456 MIDDLE EAST & AFRICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 457 MIDDLE E